Bridgefront Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$657K Buy
+33,675
New +$668K 0.17% 196
2025
Q4
– Sell
-12,366
Closed -$231K – 747
2025
Q3
$231K Buy
+12,366
New +$231K 0.07% 481
2024
Q1
– Sell
-10,680
Closed -$152K – 535
2023
Q4
$152K Sell
10,680
-22,093
-67% -$314K 0.12% 323
2023
Q3
$457K Buy
+32,773
New +$419K 0.32% 91
2022
Q2
– Sell
-10,040
Closed -$149K – 417
2022
Q1
$149K Buy
+10,040
New +$137K 0.18% 221
2021
Q2
– Sell
-22,893
Closed -$397K – 870
2021
Q1
$397K Buy
22,893
+6,333
+38% +$111K 0.12% 331
2020
Q4
$288K Buy
+16,560
New +$264K 0.1% 388

Other funds holding SBRA

Bridgefront Capital's SBRA Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 33,675 shares worth $657K. The stake represents 0.17% of the portfolio and ranks #196 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in SBRA as recently as Q3 2025.

Bridgefront Capital first reported a position in SBRA in Q4 2020 and has held it in 7 quarters since. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Bridgefront Capital held 33,675 shares of Sabra Healthcare REIT worth $657K as of Q2 2026.
  • Sabra Healthcare REIT was a new Bridgefront Capital position in Q2 2026.
  • Sabra Healthcare REIT made up 0.17% of Bridgefront Capital's portfolio in Q2 2026, its #196 holding.
  • Bridgefront Capital first reported a position in Sabra Healthcare REIT in Q4 2020 and has held it in 7 quarters since.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.